Life sciences organizations have invested heavily in data and analytics, yet timely decision making remains a challenge. In this interview, Erin Mistry, CEO of Within3, and Ian McKinnon, Managing Director and Global Head of Consulting at Within3, explain why the issue is often not access to data but ownership of decisions. They explore how organizational silos, unclear accountability and delays in distributing insights can slow action even when information is readily available.
The conversation also examines how organizations can better recognize market shifts, share insights across commercial, medical affairs and market access teams, and balance compliance requirements with the need for speed. Looking ahead, Mistry and McKinnon discuss the growing influence of AI and automation, while emphasizing the enduring value of human judgment, therapeutic expertise and cross-functional industry knowledge. They share their perspective on building faster, more connected decision-making processes across life sciences organizations.